CN Patent

CN116120163B — 一种贝派地酸的合成方法及其中间体

Assigned to Anhui Ailide Pharmaceutical Co ltd · Expires 2024-05-28 · 2y expired

What this patent protects

本发明公开了贝派地酸的新中间体化合物，同时还公开了贝派地酸的合成方法，该方法缩短了路线步骤，降低了工艺成本，并且改进了最终产品的纯度和收率，适合放大生产。

USPTO Abstract

本发明公开了贝派地酸的新中间体化合物，同时还公开了贝派地酸的合成方法，该方法缩短了路线步骤，降低了工艺成本，并且改进了最终产品的纯度和收率，适合放大生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN116120163B
Jurisdiction
CN
Classification
—
Expires
2024-05-28
Drug substance claim
No
Drug product claim
No
Assignee
Anhui Ailide Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.